Corcept Therapeutics Incorporated (NASDAQ:CORT): A Fundamentally Weighted Stock for Long-Term Investors
Corcept Therapeutics Incorporated (NASDAQ:CORT) previous close was $21.58 while the outstanding shares total 116.82M. The firm has a beta of 0.71, a 12-month trailing P/E